778 related articles for article (PubMed ID: 19846917)
21. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.
Han YH; Park WH
Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels.
Han YH; Kim SZ; Kim SH; Park WH
Lung Cancer; 2008 Mar; 59(3):301-14. PubMed ID: 17920721
[TBL] [Abstract][Full Text] [Related]
23. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
24. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
Han YH; Park WH
Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
[TBL] [Abstract][Full Text] [Related]
25. Effects of carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone on the growth inhibition in human pulmonary adenocarcinoma Calu-6 cells.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Toxicology; 2009 Nov; 265(3):101-7. PubMed ID: 19819288
[TBL] [Abstract][Full Text] [Related]
26. The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione.
Han YH; Park WH
Mol Cell Biochem; 2010 Jan; 333(1-2):211-9. PubMed ID: 19714450
[TBL] [Abstract][Full Text] [Related]
27. 2,4-dinitrophenol induces G1 phase arrest and apoptosis in human pulmonary adenocarcinoma Calu-6 cells.
Han YH; Kim SW; Kim SH; Kim SZ; Park WH
Toxicol In Vitro; 2008 Apr; 22(3):659-70. PubMed ID: 18276104
[TBL] [Abstract][Full Text] [Related]
28. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.
Park WH
Mol Med Rep; 2011; 4(1):193-04. PubMed ID: 21461585
[TBL] [Abstract][Full Text] [Related]
29. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
30. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
Cheng B; Yang X; An L; Gao B; Liu X
Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park WH
Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
[TBL] [Abstract][Full Text] [Related]
34. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis.
Yan W; Arai A; Aoki M; Ichijo H; Miura O
Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470
[TBL] [Abstract][Full Text] [Related]
35. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
Park WH
Oncol Rep; 2018 Feb; 39(2):860-870. PubMed ID: 29207156
[TBL] [Abstract][Full Text] [Related]
36. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
Fröhlich E; Czarnocka B; Brossart P; Wahl R
Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326
[TBL] [Abstract][Full Text] [Related]
38. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
Han YH; Moon HJ; You BR; Park WH
Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
[TBL] [Abstract][Full Text] [Related]
39. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
[TBL] [Abstract][Full Text] [Related]
40. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
